Next-generation Hydrogel spacer offers enhanced visibility via CT Scan to optimize treatment planning for patients undergoing radiation for prostate cancer. … continue reading “U.S. Launch for Boston Scientific SpaceOAR Vue™ Hydrogel”
Boston Scientific
Rezūm™ Water Vapor BPH Therapy Effective After Five Years
New clinical study results say the Rezūm System provided significant, sustained improvement of lower urinary tract symptoms (LUTS) and quality of … continue reading “Rezūm™ Water Vapor BPH Therapy Effective After Five Years”
CE Mark for “World First” Single-Use Duodenoscope, EXALT Model D
Boston Scientific Corporation has gained the CE Mark and initiated a limited market release of the EXALT™ Model D Single-Use (disposable) … continue reading “CE Mark for “World First” Single-Use Duodenoscope, EXALT Model D”
Glenfield to become one of first UK Hospitals to offer Boston Scientific’s WATCHMAN FLX™
Leicester’s Glenfield Hospital is to introduce the latest stroke-preventing cardiac implant, through Althea’s Consumable Management Service (CMS). Background Atrial fibrillation … continue reading “Glenfield to become one of first UK Hospitals to offer Boston Scientific’s WATCHMAN FLX™”
CE Mark for Boston Scientific’s VERCISE™ Neural Navigator 3 Programming Software
Boston Scientific Corporation has announced the CE Mark approval of its Vercise™ Neural Navigator 3 directional Deep Brain Stimulation (DBS) programming … continue reading “CE Mark for Boston Scientific’s VERCISE™ Neural Navigator 3 Programming Software”
Boston Scientific’s New TACTRA™ Penile Prosthesis
This new implant provides patients with a durable, natural-feeling implant for the treatment of erectile dysfunction. Background Erectile dysfunction (ED) … continue reading “Boston Scientific’s New TACTRA™ Penile Prosthesis”
Boston Scientific to Acquire Symetis
Company says acquisition demonstrates continued commitment to structural heart portfolio
U.S. FDA Approval for Boston Scientific’s EMBLEM™ MRI S-ICD System
Approval grants MR-conditional labeling to all EMBLEM S-ICD Systems, further expanding the company’s ImageReady™ portfolio
U.S. FDA Approval for Boston Scientific’s Precision Montage™ MRI Spinal Cord Stimulator System
Full-Body MRI access expands Spinal Cord Stimulation offering and brings customized therapy to more patients suffering from chronic pain
Boston Scientific Launches Single-Use Flexible Ureteroscope
Ureteroscopes are used 4600 times a day to examine the urinary tract. Boston Scientific is claiming a first with its new disposable offering, which does sound like a game changer
FDA Approval And CE Mark for Boston Scientific’s DVT Catheter
ZelanteDVT catheter is the first AngioJet catheter designed specifically to treat DVT
Boston Scientific Targets Endoscopic Ultrasound Leadership with Xlumena Buy
Boston Scientific Corporation is to acquire Xlumena, Inc., developer of Endoscopic Ultrasound-guided transluminal drainage devices
FDA and CE Mark Approval for Boston Scientific’s Thinner S-ICD System
Boston Scientific will be hoping its new S-ICD will prove popular based on its advantages over conventionally placed leads
FDA Approves Boston’s WATCHMAN™ Left Atrial Appendage Closure Device
First-Of-Its-Kind alternative to long-term Warfarin therapy for stroke risk reduction in patients with non-valvular atrial fibrillation
Launch and First Implant of Boston Scientific’s Long-Lasting ICD
The new Extended Longevity ICDs, featuring EnduraLife battery technology promise almost twelve years
Retrospective Study Says Boston’s Spinal Cord Stimulator Works at 12 Months
Whatever the value of retrospective data, Boston Scientific is touting results that make a solid case for its Precision Spectra spinal cord stimulator system